Back to Search Start Over

In vivo analysis of FBXO45-mediated fibrosis and liver tumorigenesis in a chemically induced mouse model of hepatocellular carcinoma.

Authors :
Zhang J
Lin XT
Fang L
Xie CM
Source :
STAR protocols [STAR Protoc] 2023 Mar 17; Vol. 4 (1), pp. 102124. Date of Electronic Publication: 2023 Feb 15.
Publication Year :
2023

Abstract

FBXO45, an E3 ubiquitin ligase highly expressed in liver tumors, is positively correlated with poor survival of hepatocellular carcinogenesis (HCC) patients, but whether FBXO45 drives HCC tumorigenesis remains largely unclear. Here, we describe a protocol that shortens the observation period for HCC tumorigenesis to assess the effects of FBXO45 in a DEN/CCl <subscript>4</subscript> -induced HCC mouse model. We describe steps for chemical induction of HCC in FBXO45-overexpressing mice, followed by tissue collection and pathology assessment via quantitative real-time PCR, histology, and immunohistochemistry. For complete details on the use and execution of this protocol, please refer to Lin et al. (2021). <superscript>1</superscript> .<br />Competing Interests: Declaration of interests The authors declare no competing interests.<br /> (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
2666-1667
Volume :
4
Issue :
1
Database :
MEDLINE
Journal :
STAR protocols
Publication Type :
Academic Journal
Accession number :
36853700
Full Text :
https://doi.org/10.1016/j.xpro.2023.102124